What are the guidelines for using epinephrine (adrenaline) in dental procedures for patients taking beta blockers (beta-adrenergic blocking agents)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Use of Epinephrine in Dental Procedures for Patients on Beta Blockers

Epinephrine can be safely used in dental procedures for patients taking beta blockers, but the lowest effective concentration should be used and careful monitoring is recommended. 1, 2

Safety Profile and Recommendations

  • The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure concluded that although adverse events may occur in uncontrolled hypertensive patients during dental procedures, the use of epinephrine has minimal effect 1

  • For patients with stable, controlled cardiovascular conditions (including those on beta blockers):

    • Small amounts of local infiltrative anesthesia with epinephrine have been demonstrated to be safe in dental surgery 2
    • Concentrations of 1:100,000 or 1:200,000 are recommended as they provide effective vasoconstriction 2
    • Use the lowest effective concentration of epinephrine to minimize potential side effects 2, 3

Potential Concerns and Monitoring

Theoretical Risks

  • Non-selective beta blockers (like propranolol) can potentially interact with epinephrine by:
    • Blocking epinephrine's beta effects while leaving alpha effects unopposed 4, 5
    • Decreasing plasma clearance of epinephrine (to approximately 55% of normal) 6
    • Potentially increasing the duration of anesthesia by up to 58% for pulpal anesthesia and 19% for soft-tissue anesthesia 7

Clinical Evidence of Safety

  • Multiple studies have shown no significant difference in adverse cardiovascular outcomes when using epinephrine-containing local anesthetics in patients with coronary artery disease 8, 9
  • No significant differences in blood pressure, heart rate, or evidence of ischemia and arrhythmias have been observed between patients receiving anesthesia with or without epinephrine 8

Practical Approach

  1. Pre-procedure assessment:

    • Confirm that cardiovascular conditions are stable and controlled
    • Review current medications, particularly type of beta blocker (selective vs. non-selective)
  2. Anesthetic administration:

    • Use the lowest effective concentration of epinephrine (1:100,000 or 1:200,000) 2, 3
    • Administer slowly and in small amounts
    • Consider aspiration technique to avoid intravascular injection
  3. Monitoring:

    • Monitor blood pressure and heart rate before, during, and after the procedure
    • Be alert for signs of cardiovascular changes
  4. Post-procedure:

    • Inform patients on beta blockers that the duration of anesthesia may be prolonged 7
    • Ensure follow-up if needed

Special Considerations

  • For patients with uncontrolled hypertension or unstable cardiovascular disease, consider postponing elective dental procedures until medical conditions are stabilized 10
  • If a patient's ability to safely undergo a procedure is in question due to cardiovascular disease, consultation with the patient's cardiologist is recommended 2

While there are theoretical concerns about interactions between beta blockers and epinephrine, clinical evidence supports the safety of using appropriate concentrations of epinephrine in dental anesthetics for patients on beta blockers with stable cardiovascular conditions.

References

Guideline

guidelines for the use of local anesthesia in office-based dermatologic surgery.

Journal of the American Academy of Dermatology, 2016

Guideline

Anesthesia for Minor Surgical Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

clinical practice guideline: immunotherapy for inhalant allergy.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2024

Research

Effect of beta-adrenoreceptor blockade with nadolol on the duration of local anesthesia.

Journal of the American Dental Association (1939), 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.